Related Experiment Videos
Classic Kaposi's sarcoma as a first primary neoplasm
J Iscovich1, P Boffetta, P Brennan
1Israel Cancer Registry, Ministry of Health, Jerusalem. iscovich@netvision.net.il
International Journal of Cancer
|February 6, 1999
Summary
Patients with classic Kaposi's sarcoma (CKS) do not face an overall higher risk of secondary cancers. However, they show an increased risk for non-Hodgkin's lymphoma (NHL), suggesting shared risk factors.
Area of Science:
- Oncology
- Epidemiology
- Cancer Research
Background:
- Classic Kaposi's sarcoma (CKS) diagnosis has been anecdotally linked to increased risks of subsequent neoplasms.
- Understanding secondary cancer risks in CKS patients is crucial for comprehensive patient management and risk stratification.
Purpose of the Study:
- To evaluate the risk of secondary neoplasms in a large cohort of patients diagnosed with primary classic Kaposi's sarcoma (CKS).
Main Methods:
- Nation-wide analysis of 1,016 Jewish Israeli patients with primary CKS (1961-1992), excluding HIV-positive cases.
- Data sourced from the Israel Cancer Registry; secondary neoplasm risk calculated using standardized incidence ratios (SIR) and rate ratios (RR), stratified by age, origin, and gender.
Main Results:
- Overall risk for secondary neoplasms was not elevated (SIR = 1.01).
- Significant excesses observed for non-Hodgkin's lymphoma (NHL) (SIR = 3.94) and cutaneous malignant melanoma (SIR = 5.81).
- Migrants from Eastern Europe showed higher risks for solid tumors (RR = 3.01) and NHL (RR = 4.10).
Conclusions:
- Primary CKS patients do not have an increased overall risk for subsequent cancers.
- The elevated risk of NHL suggests shared underlying risk factors between CKS and NHL.
- Further research into common etiologies for CKS and NHL is warranted.